Elsevier

Human Pathology

Volume 26, Issue 1, January 1995, Pages 86-91
Human Pathology

Original contribution
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer☆

https://doi.org/10.1016/0046-8177(95)90119-1Get rights and content

Abstract

Solid tumors must induce a vascular stroma to grow beyond a minimal size, and the intensity of the angiogenic response has been correlated with prognosis in breast cancer patients. Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a secreted protein that has been implicated in tumor-associated angiogenesis. Vascular permeability factor directly stimulates endothelial cell growth and also increases microvascular permeability, leading to the extravasation of plasma proteins, which alter the extracellular matrix in a manner that promotes angiogenesis. To determine whether VPF has a role in breast cancer, we used in situ hybridization to study VPF mRNA expression in normal breast tissue (13 specimens), comedo-type ductal carcinoma in situ (DCIS) (four specimens), infiltrating ductal carcinoma (12 specimens), infiltrating lobular carcinoma (two specimens), metastatic ductal carcinoma (three specimens) and metastatic lobular carcinoma (one specimen). Vascular permeability factor mRNA was expressed at a low level by normal duct epithelium but was expressed at high levels in tumor cells in all cases of comedo-type DCIS, infiltrating ductal carcinoma, and metastatic ductal carcinoma. In contrast, VPF mRNA was not expressed at high levels in infiltrating lobular carcinoma. We also used in situ hybridization to study the expression of two recently described endothelial cell surface VPF receptors, flt-1 and kdr. Vascular permeability factor receptor mRNA was strongly expressed in endothelial cells of small vessels adjacent to malignant tumor cells in DCIS, infiltrating ductal carcinoma, and metastatic ductal carcinoma. In contrast, no definite labeling for receptor mRNA was detected in infiltrating lobular carcinoma or nonmalignant breast tissue. The intense expression of VPF mRNA by breast carcinoma cells and of VPF receptor mRNA by endothelial cells of adjacent small blood vessels provides strong evidence linking VPF expression to the angiogenesis associated with comedo-type DCIS, infiltrating ductal, and metastatic ductal breast carcinoma.

References (40)

  • N Weidner et al.

    Tumor angiogenesis and metastasis—Correlation in invasive breast carcinoma

    N Engl J Med

    (1991)
  • N Weidner et al.

    Tumor angiogenesis: A new significant and independant prognostic indicator in early-stage breast carcinoma

    J Natl Cancer Inst

    (1992)
  • DR Senger et al.

    Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor

    Cancer Res

    (1990)
  • G Conn et al.

    Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor

  • D Gospodarowicz et al.

    Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells

  • PJ Keck et al.

    Vascular permeability factor, an endothelial cell mitogen related to PDGF

    Science

    (1989)
  • DW Leung et al.

    Vascular endothelial growth factor is a secreted angiogenic mitogen

    Science

    (1989)
  • DT Connolly et al.

    Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

    J Clin Invest

    (1989)
  • KJ Kim et al.

    Inhibition of vascular endothelial growth factor induced angiogenesis supresses tumor growth in vivo

    Nature

    (1993)
  • KA Houck et al.

    The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA

    Mol Endocrinol

    (1991)

    • Cited by (0)

    ☆

    Supported by US Public Health Service NIH Grants No. CA50453 and CA58845 (to HFD) and CA43967 (to DRS).

    View full text
    Copyright © 1995 Published by Elsevier Inc.